Keyphrases
Seasonal Influenza Vaccine
76%
Influenza
74%
Adverse Events
70%
Older Adults
70%
Sex Effect
68%
Aging Effect
65%
Healthcare Workers
57%
Revaccination
51%
Influenza Vaccination
49%
Vaccination
46%
Pre-vaccination
46%
Biological Sex
40%
Influenza Vaccine
40%
Titer
38%
Gender Differences
38%
Sex Differences
35%
Gender Score
35%
Sex-gender
32%
Neutralizing Antibodies
32%
Fluidization Quality
32%
Screening Tool
32%
Biological Gender
32%
Body Mass Index
32%
Adverse Reactions
32%
Antibody Response
32%
COVID-19
32%
COVID-19 Vaccination
32%
Seasonal Influenza Vaccination
32%
Vaccine Acceptance
32%
Psoriasis
32%
Humoral Immune Response
32%
Biomedical Research
32%
Gender Dimensions
32%
Female Healthcare Workers
24%
Host Factors
21%
Vaccination Coverage
21%
COVID-19 Vaccine
19%
Pre-existing Immunity
16%
Repeated Vaccination
16%
Hemagglutination Inhibition
16%
Humoral Immunity
16%
UV Index
16%
Female Population
16%
Influenza Season
16%
Bem Sex Role Inventory
16%
H3N2
13%
H1N1
13%
Young Female
13%
Sociodemographic Characteristics
13%
Vaccination Strategy
10%
Medicine and Dentistry
Adverse Event
98%
Gender and Sex
71%
Seasonal Influenza
65%
Influenza Vaccine
60%
Influenza Vaccination
44%
Sex Difference
37%
COVID-19 Vaccination
32%
Cutaneous T Cell Lymphoma
32%
Antibody Response
32%
Nodular Melanoma
32%
Cutaneous Melanoma
32%
T Cell
32%
COVID-19
32%
Biological Marker
32%
Vaccine Acceptance
32%
Neutralizing Antibody
32%
Body Mass Index
32%
Psoriasis
32%
Mycosis fungoides
13%
Cohort Analysis
11%
Influenza A Virus (H1N1)
10%
Nurse
9%
COVID-19 Vaccine
9%
Anticipation
6%
Childbirth
6%
Health System
6%
Public Health
6%
CD8 Antigen
6%
Dermatitis
6%
Occupational Health
6%
Seroconversion
5%
Influenza A Virus (H3N2)
5%
Serosurvey
5%
Host Factor
5%
Influenza A (H3N2)
5%
Vaccine Strain
5%
Diethylstilbestrol
5%
Immunology and Microbiology
Vaccination Policy
100%
Influenza
98%
Vaccine Efficacy
46%
Tetanus Antibody
32%
Immunoglobulin G
32%
Antibody Response
32%
Humoral Immunity
32%
Antibody Blood Level
32%
Gender and Sex
32%
Body Mass
32%
Liquid
32%
Titer
24%
Neutralizing Antibody
16%
Tetanus Vaccine
16%
Influenza Vaccine
11%
Antibody Titer
10%
Host Factor
9%
Sex Difference
9%
Influenza A Virus (H1N1)
9%
Influenza A Virus (H3N2)
9%
Drug Megadose
8%
Hemagglutination Inhibition
7%
